Lloyd Price

SEPTEMBER 2, 2023

Growth of the life sciences sector: The life sciences sector is expected to continue to grow in 2023, driven by the development of new drugs and therapies, as well as the increasing demand for personalized medicine. The overall outlook for the European HealthTech M&A market in 2023 is positive.

Life Science 64

Life Science Digital Health EHR BioTech 64

Healthcare IT Today

JANUARY 8, 2024

Jane Reed, Director of Life Sciences at Linguamatics, an IQVIA company Pharmaceutical developers have always prioritized drug safety. Convenience, cost, and consumerism remain top-of-mind going into the New Year, and more healthcare stakeholders are considering offering at-home tests to close gaps in care and advance better health.

Health IT 84

Health IT Drug Development Pharmaceuticals BioTech 84

Healthcare IT Today

OCTOBER 11, 2023

which will partner with 20+ health system partners to guide their transition to value-based care and potentially acquire a health system “where we can demonstrate the blueprint of this transformation for the rest of the industry.” Elation Health released an integrated EHR and billing suite for primary care.

Life Science 71

Life Science EHR BioTech RCM 71